Stay updated with breaking news from Bivalent. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Jerusalem, April 14: US pharma giant Pfizer's new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years and above, according to a study published in The Lancet Infectious Diseases.
The updated COVID-19 vaccine booster shots provide virtually no protection against infection and quickly waning shielding against hospitalization, ...
/cloudfront-ap-southeast-2.images.arcpublishing.com/nzme/NS5OEP7FLVCYDGM5F53LWBDXMU.png)
The full story of the trial that had it all.
Last week, the World Health Organisation (WHO) updated its Covid-19 vaccination recommendations, saying healthy children and adolescents may not necessarily need a vaccine, while the elderly and at-risk groups should receive an additional booster dose six to 12 months after their last dose.The
The CDC and the FDA have yet to make a recommendation for another bivalent booster dose, but experts are already recommending it for high-risk groups.